Shenzhen HighTide Biopharmaceutical, Ltd.
Suite A228, NO. 19 Gaoxin C.1st Ave.,Nanshan District
Shenzhen HighTide Biopharmaceutical Ltd., a subsidiary of Shenzhen Hepalink Pharmaceutical Co., Ltd., was founded in 2011 with the focus to develop innovative peptide therapeutics for unmet medical needs including: diabetes and diabetic complications, antibiotic-resistant bacterial infections, cancers and other debilitating diseases.
CEO: Liping Liu
Shenzhen HighTide Biopharmaceutical